Deep ResearchMarket AnalysisSeptember 6, 2026 · 20 min read · VEMERIX

Public Price Benchmarks for Single-Use Consumables (2026): Medicare, UNICEF and the US Import Work Order

Keep reimbursement, procurement awards and landed costs separate when building a consumables bid.

Procurement
Sealed injection and wound-care supplies beside a calculator, illustrating consumable quotation comparisons.

Start with the transaction you are pricing

A pump rental month, a complete dressing change, a professional application service and a syringe award are different units. They also sit at different points in the payment chain. Comparing their dollar values without those distinctions can produce a bid that looks attractive on paper but fails the customer's actual purchasing model.

For a distributor supplying a Medicare billing supplier, a local allowable is a useful input to the customer's economics. For a hospital buying under its own contract, that same allowable may be background information. A UNICEF award is a useful reference for a comparable presentation and delivery term; it does not reveal the winning supplier's cost, profitability or willingness to serve another buyer at that price.

Build the comparison around five fields: the exact product or service, the billable or saleable unit, the buyer and care setting, the geography and effective period, and what the price includes. Only then place the public benchmark beside the supplier quotation. Keep taxes, freight, insurance, wastage, financing, distribution and service costs visible instead of hiding them in a single markup.

Medicare NPWT: locate the applicable schedule before calculating a margin

The July 2026 DMEPOS national file gives a reproducible snapshot for three familiar durable NPWT codes. E2402 RR is an electric pump rental; A6550 is the complete dressing set for a change; A7000 NU is a new disposable canister. The NPWT policy article describes the coding and required components. A reimbursement code is not a declaration that every product marketed with a similar name meets coverage or coding requirements. 19

Selected NPWT amounts in the July 2026 national DMEPOS file
HCPCSItemNon-rural range (USD)Non-rural median (USD)Rural (USD)
E2402 RRNPWT electrical pump, per rental month748.28 to 1,727.82 (continental max 881.94)829.211,504.41
A6550NPWT dressing set, each31.08 to 37.5431.6733.70
A7000 NUDisposable canister for pump, each9.24 to 12.4210.5010.23 to 11.58

Unweighted summaries of 53 non-rural jurisdiction columns; separate former competitive bidding area schedules are not included.

  • Method: E2402 RR, A6550 and A7000 NU without KE. Non-rural minimum/median/maximum include AK, HI, PR and VI. Rural zero entries for non-applicable columns excluded.

Source: CMS DMEPOS fee schedule, July 2026 — VEMERIX analysis, accessed September 2026

We calculated the non-rural minimum, median and maximum across 53 jurisdiction columns in the national file. Each jurisdiction receives equal weight; claims volume is not available in that calculation. Alaska, Hawaii, Puerto Rico and the Virgin Islands are included. The E2402 RR maximum is $1,727.82 across all columns, while the maximum among the contiguous states and District of Columbia is $881.94. Calling the latter a national maximum would exclude material geography. 1

The rural values also need their own scope. E2402 RR is $1,504.41 in the applicable populated rural columns; A6550 is $33.70. A7000 NU ranges from $10.23 to $11.58. Zero entries in non-applicable rural columns were excluded rather than treated as free supplies. We selected A7000 NU without the KE modifier; mixing modifier rows would change the question being answered. 1

The national file is not the complete universe of payable locality amounts. CMS publishes a separate former competitive bidding area file. For example, that file contains an E2402 RR amount of $946.62 for Aiken and an A6550 amount of $30.97 for Albuquerque. Those examples sit outside the corresponding contiguous-state maximum or national-file minimum above. The lesson is to select the beneficiary's applicable schedule and locality before using a benchmark in a quote. 12

An allowable is also not the same as the Medicare payment recorded in historical claims. Payment may depend on assignment, deductible, coinsurance, coverage and other claim circumstances. A commercial model must distinguish the allowed amount, expected collections and acquisition cost. The median A6550 amount of $31.67 alone cannot establish what a particular customer can profitably pay for a dressing. 4910

Surgical dressings: the code's size, border and billing unit matter

The fee file includes fields named ceiling and floor for surgical dressings. These are reimbursement calculation fields, not bounds on manufacturing cost. They should not be presented as a universal price corridor: non-continental payment rules can produce jurisdiction amounts outside those fields. For example, A6209 in Puerto Rico is $12.82 in this file, above its $10.65 ceiling field. 12

Selected surgical-dressing ceiling fields, July 2026 (USD)
Alginate ≤16 sq in (A6196)Ceiling (USD): 10.4910.49Alginate >16–48 sq in (A6197)Ceiling (USD): 23.4423.44Foam ≤16 sq in (A6209)Ceiling (USD): 10.6510.65Foam >16–48 sq in (A6210)Ceiling (USD): 28.428.4Foam >48 sq in (A6211)Ceiling (USD): 41.8641.86Foam adhesive ≤16 sq in (A6212)Ceiling (USD): 13.8413.84Hydrocolloid ≤16 sq in (A6234)Ceiling (USD): 9.339.33Hydrocolloid >16–48 sq in(A6235)Ceiling (USD): 23.9723.97Hydrocolloid >48 sq in (A6236)Ceiling (USD): 38.8338.83Hydrogel ≤16 sq in (A6242)Ceiling (USD): 8.638.63Hydrogel >16–48 sq in (A6243)Ceiling (USD): 17.5617.56Hydrogel >48 sq in (A6244)Ceiling (USD): 55.9955.99Composite ≤16 sq in (A6203)Ceiling (USD): 4.84.8Specialty absorptive ≤16 sq in(A6251)Ceiling (USD): 2.842.84Sterile gauze ≤16 sq in (A6402)Ceiling (USD): 0.150.15
View chart data
CategoryCeiling (USD)
Alginate ≤16 sq in (A6196)10.49
Alginate >16–48 sq in (A6197)23.44
Foam ≤16 sq in (A6209)10.65
Foam >16–48 sq in (A6210)28.4
Foam >48 sq in (A6211)41.86
Foam adhesive ≤16 sq in (A6212)13.84
Hydrocolloid ≤16 sq in (A6234)9.33
Hydrocolloid >16–48 sq in (A6235)23.97
Hydrocolloid >48 sq in (A6236)38.83
Hydrogel ≤16 sq in (A6242)8.63
Hydrogel >16–48 sq in (A6243)17.56
Hydrogel >48 sq in (A6244)55.99
Composite ≤16 sq in (A6203)4.8
Specialty absorptive ≤16 sq in (A6251)2.84
Sterile gauze ≤16 sq in (A6402)0.15

These are national file ceiling fields, not acquisition-price limits. Non-continental payable amounts can exceed them; full code descriptors appear below.

  • Method: Ceiling amount per HCPCS code from the national fee schedule file.

Source: CMS DMEPOS fee schedule, July 2026 — VEMERIX analysis, accessed September 2026

The chart compares selected ceiling fields. It does not isolate the causal effect of material or absorption capacity on price. Codes differ in surface area, construction and border configuration, and a fee schedule is an administrative pricing system. For procurement, the useful next step is to match the quoted item to the full descriptor and intended use.

All 21 code summaries below were checked against the official July 2026 HCPCS file. Wound-cover sizes refer to the pad, not automatically the outside dimensions of an adhesive border. “Over 16 through 48” excludes 16 and includes 48. These are abbreviated purchasing references; the official descriptor remains the coding source. 11

HCPCSVerified descriptor summary and unitCeiling field, USDFloor field, USD
A6196Sterile alginate or other fiber-gelling cover, pad ≤16 sq in, each10.498.92
A6197Same cover, pad >16 through 48 sq in, each23.4419.92
A6199Sterile alginate or other fiber-gelling filler, per 6 inches7.526.39
A6203Sterile composite cover, pad ≤16 sq in, any size adhesive border, each4.804.08
A6209Sterile foam cover, no adhesive border, pad ≤16 sq in, each10.659.05
A6210Same foam cover, pad >16 through 48 sq in, each28.4024.14
A6211Same foam cover, pad >48 sq in, each41.8635.58
A6212Sterile foam cover, pad ≤16 sq in, any size adhesive border, each13.8411.76
A6234Sterile hydrocolloid cover, no adhesive border, pad ≤16 sq in, each9.337.93
A6235Same hydrocolloid cover, pad >16 through 48 sq in, each23.9720.37
A6236Same hydrocolloid cover, pad >48 sq in, each38.8333.01
A6242Sterile hydrogel cover, no adhesive border, pad ≤16 sq in, each8.637.34
A6243Same hydrogel cover, pad >16 through 48 sq in, each17.5614.93
A6244Same hydrogel cover, pad >48 sq in, each55.9947.59
A6251Sterile specialty absorptive cover, no adhesive border, pad ≤16 sq in, each2.842.41
A6402Sterile non-impregnated gauze, no adhesive border, pad ≤16 sq in, each0.150.13
A6403Same gauze, pad >16 through 48 sq in, each0.580.49
A6407Sterile non-impregnated packing strip, width ≤2 inches, per linear yard2.662.26
A6442Non-elastic, non-sterile conforming bandage, width <3 inches, per yard0.230.20
A6449Elastic light-compression bandage, width ≥3 and <5 inches, per yard2.502.13
A6452Elastic high-compression bandage, width ≥3 and <5 inches, per yard; resistance ≥1.35 foot-pounds at 50% maximum stretch8.407.14

For a tender response, keep the supplied unit and billing unit in separate columns. A box price must be converted using its actual count; a roll cannot be compared with a per-yard fee without its usable length. Likewise, an adhesive-border product should not inherit the reference price of a borderless product just because the pad material matches. Clinical selection and coverage require their own review. 91011

Disposable NPWT: service counts and payment settings tell different stories

The CMS Medicare Physician & Other Practitioners dataset used here is by Geography and Service. The stored extract contains 20,830 rows across multiple procedures and geographies. The analysis uses only 88 national NPWT rows for 2013–2024; it does not treat all 20,830 rows as NPWT claims. Each row is an aggregate, not a patient or individual claim. 34

National Medicare professional NPWT services, 2015–2024
Durable pump services (97605 + 97606)Disposable services (97607 + 97608)
017.5k35k52.6k70.1k2015201620172018201920202021202220232024
View chart data
CategoryDurable pump services (97605 + 97606)Disposable services (97607 + 97608)
2015603851640
2016615853181
2017666664912
2018692026340
2019700827282
2020661327620
2021624579907
20225500410091
20235374612669
20245304514176

Disposable-code services rose 8.64 times from 2015 to 2024; durable-code services fell 24.3% from 2019. Counts are services, not unique patients or device sales.

  • Method: National total services summed across places of service; durable = 97605 + 97606; disposable = 97607 + 97608.

Source: CMS Medicare Physician & Other Practitioners — by Geography and Service; national rows, analysis September 5, 2026

Summing national total services across places of service, codes 97607 and 97608 increased from 1,640 services in 2015 to 14,176 in 2024: 8.64 times the initial count, or a 764.4% increase. Codes 97605 and 97606 fell from 70,082 services in 2019 to 53,045 in 2024, a 24.3% decline. These are historical billed services in this dataset. They do not count unique patients, units purchased, all Medicare NPWT activity or the share of wounds treated with each format. They cannot establish clinical substitution or an irreversible market transition. 3

Use service-weighted payments, then separate office and facility

To combine aggregate payment rows, multiply each row's average Medicare payment by its service count, sum those products and divide by total services. A simple mean of office and facility averages gives both settings equal weight regardless of their activity. For 97607, the 2024 service-weighted result is $135.46. 34

Service-weighted Medicare payment per disposable NPWT service (USD)
97607 (≤50 sq cm)97608 (>50 sq cm)
037.6375.27112.91150.542015201620172018201920202021202220232024
View chart data
Category97607 (≤50 sq cm)97608 (>50 sq cm)
201522.6325.43
201622.7624.82
201722.2824.7
201822.725.76
201923.1725.3
202070.1443.77
2021114.4647.69
2022150.5456.69
2023143.6668.53
2024135.4669.79

National office and facility rows combined using service weights. Medicare payment excludes deductible and coinsurance; it is not a device purchase budget.

  • Method: For each year/code: sum(total_services × avg_medicare_payment) / sum(total_services); round only final result to cents.

Source: CMS Medicare Physician & Other Practitioners — by Geography and Service; national rows, analysis September 5, 2026

Code2024 servicesService-weighted Medicare payment, USDOffice average, USDFacility average, USD
9760711,815135.46258.0016.37
976082,36169.79257.2719.29

For 97607, the totals comprise 5,823 office and 5,992 facility services. For 97608, they comprise 501 office and 1,860 facility services. The wide setting difference is commercially relevant, but neither the combined average nor the office value is a stand-alone device acquisition budget. CMS's payment measure excludes beneficiary deductible and coinsurance; it is not the full allowed amount or total provider revenue. 34

The time series also cannot attribute the 2020 increase solely to a shift in setting mix. The office average for 97607 itself rose from $37.37 in 2019 to $218.52 in 2020 in the stored data. Explaining that discontinuity requires the relevant annual payment rules and coding context, beyond the descriptive comparison here. 3

Home health has a separate device-payment route

Do not carry the professional-claims chart directly into a home-health budget. Effective January 1, 2024, CMS instructs home health agencies to bill qualifying disposable NPWT devices using HCPCS A9272 on type of bill 032x. Nursing and therapy services remain paid under the home health prospective payment system. The earlier use of CPT 97607/97608 on type of bill 034x, with an OPPS-based payment, describes the pre-2024 method. 12

The new device payment starts from the physician fee schedule supply-price basis and follows the specified annual adjustment rules. It does not turn the historical professional payment average into a home-health device rate. The DME policy's treatment of A9272 must also be read within that benefit: it cannot support a claim that disposable NPWT is never covered anywhere in Medicare. Establish the provider type, benefit, bill type, service date and applicable device before quoting an expected reimbursement. 912

UNICEF awards: compare the same year, presentation and delivery term

UNICEF's published long-term arrangement tables are unusually useful procurement evidence because they identify products, suppliers, years and terms. The tables span many years, however, and a number printed beside a supplier is not necessarily a 2026 price. We re-extracted the 2026 column from each PDF and checked its page position. Blank cells were excluded rather than filled with historical awards. 5613

UNICEF syringe awards: populated 2026 cells only (USD per unit, FCA)
Minimum 2026 awardMaximum 2026 award
0.5 ml AD syringe0.02250.03880.05 ml AD syringe0.02460.0442 ml RUP syringe0.02540.05315 ml RUP syringe0.02320.058810 ml RUP syringe0.03520.0541 ml RUP syringe0.03240.0324
View chart data
CategoryMinimum 2026 awardMaximum 2026 award
0.5 ml AD syringe0.02250.0388
0.05 ml AD syringe0.02460.044
2 ml RUP syringe0.02540.0531
5 ml RUP syringe0.02320.0588
10 ml RUP syringe0.03520.054
1 ml RUP syringe0.03240.0324

Ranges reflect listed 2026 product/FCA rows. The 1 ml RUP selection has one price; historical prices and blank cells are excluded.

  • Method: Minimum and maximum of populated 2026 USD cells in the AD and RUP PDFs. Separate supplier and row counts appear in the article. Prices are awards, not manufacturing costs.

Source: UNICEF Supply Division price data — VEMERIX analysis, accessed September 2026

Presentation2026 USD range per unitDistinct listed suppliersPriced product/FCA rows
0.5 ml AD syringe0.0225–0.0388912
0.05 ml AD syringe0.0246–0.044035
2 ml RUP syringe0.0254–0.053158
5 ml RUP syringe0.0232–0.0588710
10 ml RUP syringe0.0352–0.054034
1 ml RUP syringe0.032411
5 litre safety box, USD awards0.5212–0.860069

A further 5 litre safety-box row is priced at EUR 0.3752 from PaHu Oy. It remains separate; combining it with USD observations without a stated exchange rate would create a false minimum. Across both currencies, the 2026 safety-box selection comprises seven suppliers and ten rows. 13

The syringe minima in this selection are Wuxi rows with China FCA locations. Several maxima are KD Medical rows with Morocco FCA locations even though the supplier's listed legal location is Germany. A supplier address, delivery location and customs origin are three different fields. None should silently substitute for another in a tariff model. 56

The tables describe FCA prices for containerized sea shipments under the arrangements and identify conditions such as discounts or surcharges. They do not include every cost of delivering goods to a destination hospital. Price spreads may reflect multiple contractual and product differences; this dataset does not isolate the contribution of a safety mechanism, origin or production technology. A quote below the observed range is not, by itself, evidence of unsafe manufacture, material substitution or impending default. 5613

Use the award range to form a comparable quotation request. Specify capacity, needle presentation, reuse-prevention characteristics, packaging quantities, delivery location, order volume, shelf life on arrival and the requested term. Then ask the supplier to identify deviations. The public price is the reference; the comparable specification and delivery conditions determine whether it is useful.

Use WHO specifications as a starting document, with version control

The reuse-prevention syringe sheet reviewed for this report belongs to WHO's technical specifications for 13 devices on the UN life-saving commodities list, not the separate collection of 61 medical devices. Its September 2013 version is a historical procurement template. Its activation field permits automatic or elective approaches and single or multiple aspirations, depending on the product specification. Its listed syringe standards include ISO 7886-1 and ISO 7886-4. 14

That document does not establish that every RUP syringe must have the same activation design, or that ISO 7886-2 and ISO 23908 are requirements cited by this particular sheet. Current applicable standards, editions and tender requirements must be checked for the actual device. GMDN and UNSPSC references help describe and classify an item; they are not substitutes for regulatory authorization. 14

A practical specification matrix should separate the buyer's functional requirement, the supplier's exact design, the applicable current standard or regulatory requirement, and the evidence supplied. Mark each row as demonstrated, clarification needed or not applicable with a reason. This keeps a familiar acronym from becoming a claim of compliance without a matching document.

For NPWT dressings, ask for the product's intended use, compatible system identification, complete set contents and relevant performance and sterility documentation. The CMS coding definition can help define a billable set, but it does not prove compatibility with a particular pump. VEMERIX's dressing classification guide provides related market-access questions; product-specific classification and test evidence still have to be established. 915

Tariffs: a Free general rate does not mean a duty-free entry

USITC's tariff schedule must be read with the current Chapter 99 measures, origin rules and any applicable exclusions. The selected headings below are a starting reference for classification review, not an assignment of a code to a reader's product. A composite NPWT kit, for example, needs its own analysis of components and presentation. 16

Selected US tariff headings: starting points for an entry review
HTS headingDescription for orientationGeneral rate2024 action: China-origin component
9018.31.00Syringes, with or without needlesFree100%; temporary enteral treatment ended January 1, 2026
9018.32.00Tubular metal needles; suture needlesFree100% from September 27, 2024
9018.39.00Catheters, cannulae and similarFreeCheck applicable Chapter 99 measures
3005.10.10 / 3005.10.50Selected adhesive dressingsFreeCheck applicable Chapter 99 measures
3005.90.10 / 3005.90.50Selected other dressings, gauze and bandagesFreeCheck applicable Chapter 99 measures
3006.10.01Selected surgical sutures and related goodsFreeCheck applicable Chapter 99 measures
4015.12.10Medical and surgical rubber glovesFree100% from January 1, 2026

Free is the general rate in these selected headings. Current Chapter 99 duties and exceptions must be checked separately; these rows do not classify an individual product.

  • Method: Selected general rates and the 2024 product-specific Section 301 component. The separate July 2026 forced-labor layer is not included in the last column.

Source: USITC HTS 2026; September 18, 2024 Section 301 modification; CBP July 23, 2026 guidance

The September 2024 Section 301 modification raised the additional China-origin duty on syringes under 9018.31.00 and needles under 9018.32.00 to 100%, effective September 27, 2024. The temporary enteral-syringe treatment ended at the start of 2026. Medical and surgical gloves under 4015.12.10 moved to 50% in 2025 and 100% in 2026 under the same action. These percentages describe that particular measure. 7

The 2026 update is material: CBP's July 23 guidance implements a separate forced-labor Section 301 action effective July 24. It lists China under 9903.05.31 at an additional 12.5%, except for products described in the specified exception headings. A 100% product-specific rate therefore cannot be advertised as the complete current tariff burden. Whether both layers apply to a particular entry requires the current classification and exception checks. 817

Dated tariff measures to check separately
Effective date / statusMeasureScope relevant to this report
September 27, 2024Technology-transfer Section 301 modificationChina-origin syringes and needles: 100% component
January 1, 2025Glove phase-in under the 2024 actionSelected China-origin medical gloves: 50% component
January 1, 2026Glove step and enteral-syringe exclusion expirySelected gloves reach 100%; enteral syringes enter the 100% component
July 24, 2026Forced-labor Section 301 actionChina: additional 12.5% under 9903.05.31, subject to listed exceptions
Investigation notice, September 2025Medical products Section 232 investigationA proceeding to monitor; the notice itself sets no duty rate

A measure-specific percentage is not the total entry duty. The July 2026 China-origin layer carries its own exceptions.

  • Method: Primary-source effective dates and measure scopes; no inferred rate from an investigation.

Source: Federal Register, September 18, 2024; CBP CSMS #69326983, July 23, 2026; BIS investigation notice, September 26, 2025

For illustration, a 100% duty component on a $50,000 customs value is $50,000. That arithmetic is not a delivered-cost quotation: it excludes other applicable duties, customs fees, freight and downstream costs. It also does not mean that every line in the landed-cost calculation doubles. Keep each applicable duty component and its legal basis as a separate row.

The medical-device Section 232 investigation is another issue to monitor. The investigation notice establishes a proceeding; it does not, by itself, establish a payable tariff rate. This dated benchmark report is not a customs-entry instruction. A bid validity clause should identify who rechecks classification, origin, exclusions and effective dates before shipment, and who bears an intervening duty change. 1819

A bid worksheet that preserves the meaning of each number

The worksheet below is a suggested commercial process, not a formula derived from CMS or UNICEF. It keeps a reimbursement reference distinct from a procurement award and leaves transaction-specific costs for the actual quotation.

Two quotation work orders using different public benchmarks
Quoted linePublic referenceScope to resolveInputs from the actual transaction
NPWT complete dressing setA6550: $31.67 unweighted non-rural median in national fileApplicable benefit, code eligibility, modifier, locality and service date; device compatibilityAcquisition cost per complete set, delivery/service costs, coverage documents, item-specific customs review
2 ml RUP syringeUNICEF 2026 awards: $0.0254–$0.0531 per unit, FCAExact presentation, needle, packaging, volume, term, shelf life and destination requirementsComparable supplier quote, responsible manufacturer, current evidence, origin and full entry duties

Fill transaction-specific cost and regulatory fields before setting a bid. No public manufacturing-cost floor is inferred.

  • Method: Illustrative workflow, not an empirically validated pricing rule.

Source: VEMERIX proposed worksheet; CMS July 2026 DMEPOS file and UNICEF 2026 RUP award column

For each line, calculate acquisition cost in the saleable unit, then add the applicable freight, insurance, duties, fees, quality-release costs and expected wastage. Allocate financing, service and overhead according to the business's own accounting method. Compare the resulting contribution at the proposed sale price with the required return and the customer's purchasing constraints.

If a team uses gross margin, define it consistently as revenue less the relevant cost of goods sold, divided by revenue. Do not confuse it with markup, which divides the same difference by cost. State which costs are included before comparing margins across suppliers or product lines. Public schedules cannot supply the missing assumptions.

Before submitting, resolve these parallel checks:

  • Product and unit: Does the quote match the required device, presentation, pack count, dimensions and usable quantity?
  • Payment context: If reimbursement is relevant, which benefit, code, modifier, setting, locality and date apply?
  • Comparable award: Does the UNICEF reference match the year, currency, delivery term and specification closely enough to be informative?
  • Landed cost: Is there an entry-specific classification and origin review, including all current duty layers and exceptions?
  • Evidence and contract: Are the required regulatory, quality, compatibility and supply documents available, and are delivery responsibilities and change clauses explicit?

Where VEMERIX can support the next step

VEMERIX presents a minimally invasive surgery and perioperative product platform. Its public product pages and a product-specific technical pack are the appropriate starting point for a sourcing enquiry. A reimbursement code or international award does not establish that a listed VEMERIX product is interchangeable with another manufacturer's device, or that VEMERIX manufactures every system it offers. 20

For a distributor or OEM enquiry, bring the intended market, product specification, expected volume, delivery term and documentation requirements. Request an itemized commercial scope, identification of the responsible manufacturer, and the applicable registration and quality evidence. The contract manufacturing buyer guide adds a supplier-evaluation framework; the benchmark tables here supply separate pricing context. 21

Methodology and limitations

This analysis prioritizes the stored R2 datasets and verifies decision-sensitive rules against primary public sources. DMEPOS values come from the July 2026 national fee file, with a separate check of the former competitive bidding area file. The 53-column median is unweighted. Rural non-applicable zero entries are excluded; code and modifier selections are retained in the working analysis. All 21 dressing summaries were rechecked against the July HCPCS file. 1211

The professional-claims calculation filters national geography rows for 97605–97608, checks uniqueness by year, code and place of service, sums services, and weights average payments by those service counts. The source covers historical fee-for-service professional activity and has its own disclosure and scope limits. It is not a census of all NPWT use. 34

UNICEF observations come only from populated 2026 cells in the cited AD, RUP and safety-box PDFs. Distinct supplier counts are separate from product/FCA row counts. Currency is not mixed. The AD and safety-box documents were updated in October 2025; the RUP document was updated in January 2026. Those document dates are not replaced by the September analysis date. 5613

The stored Comtrade extract was rejected because its reporter field was empty throughout; it cannot support country-specific trade conclusions. This report therefore makes no trade-volume ranking. WHO's historical template and the tariff measures are used only within their stated scope. The chart data, filters, corrected payment formula, rejected-source record and publication checks are retained with the research package. Readers should recheck time-sensitive schedules and entry treatment for the date of their own transaction.

Sources

  1. Centers for Medicare & Medicaid Services, DMEPOS Fee Schedule Files, July 2026 public use files - Fee schedule allowable amounts, national ceiling and floor limits, and rural and non-rural payment columns for durable medical equipment and surgical dressings.
  2. Centers for Medicare & Medicaid Services, DMEPOS Fee Schedule: July 2026 Quarterly Update, MLN Matters MM14513, 2026 - Instructions for rural fee schedule adjustments, former competitive bidding area payments, and quarterly DMEPOS updates.
  3. CMS, Medicare Physician & Other Practitioners — by Geography and Service. Stored 2013–2024 aggregates; national NPWT selection and service-weighted calculations, reviewed September 5, 2026.
  4. CMS, Medicare Physician and Other Practitioners data: Frequently Asked Questions. Aggregate measures, payment definitions and limitations.
  5. UNICEF, AD syringe pricing data, 2011–2027. Updated October 2025; only populated 2026 award cells used.
  6. UNICEF, RUP syringe pricing data, 2011–2027. Updated January 2026; only populated 2026 award cells used.
  7. Federal Register, Notice of Modification: China's Acts, Policies and Practices Related to Technology Transfer, Intellectual Property and Innovation, 89 FR 76581, 18 September 2024 - Official regulatory notice establishing Section 301 duty modifications and HTS subheadings for syringes, needles, gloves, and masks.
  8. U.S. Customs and Border Protection, CSMS #69326983: Section 301 Forced Labor Import Duties, July 23, 2026. Effective July 24; China heading 9903.05.31 and stated exceptions.
  9. Centers for Medicare & Medicaid Services, Negative Pressure Wound Therapy Pumps - Policy Article (A52511), Medicare Coverage Database, accessed September 2026 - Coding guidelines defining E2402, A6550 dressing components, A7000 canisters, and the A9272 treatment within the DME benefit.
  10. Centers for Medicare & Medicaid Services, Negative Pressure Wound Therapy Pumps - LCD (L33821), Medicare Coverage Database, accessed September 2026 - Local Coverage Determination detailing medical necessity criteria, chronic wound staging, and debridement prerequisites for NPWT coverage.
  11. CMS, July 2026 Alpha-Numeric HCPCS File, updated June 17, 2026. All 21 dressing and bandage descriptions independently checked.
  12. Centers for Medicare & Medicaid Services, Separate Payment for Disposable Negative Pressure Wound Therapy Devices on Home Health Claims, MLN Matters MM13244, 2023 - A9272 on TOB 032x from January 1, 2024; nursing/therapy remain under HH PPS; prior method and device-payment basis.
  13. UNICEF, Safety-box pricing data, 2011–2027. Updated October 2025; 2026 USD and EUR rows analyzed separately.
  14. WHO, Technical specifications for 13 medical devices on UN life-saving commodities. RUP syringe sheet, modified September 16, 2013; historical specification example.
  15. VEMERIX, The Line That Decides the Class, July 2026 - Comparative analysis of regulatory classification boundaries for advanced surgical and wound-care dressings across the US, EU, and China.
  16. U.S. International Trade Commission, Harmonized Tariff Schedule of the United States (2026), 2026 revision - General Column 1 MFN tariff rates, Column 2 non-MFN rates, and Chapter 99 trade remedy notes across medical consumables and devices.
  17. USTR, USTR Takes Action in Forced Labor Section 301 Investigations, July 23, 2026.
  18. Bureau of Industry and Security, Section 232 Investigations, U.S. Department of Commerce, accessed September 2026 - Overview and docket status of active national security trade investigations under Section 232 of the Trade Expansion Act of 1962.
  19. Federal Register, Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices, 26 September 2025 - Department of Commerce notice initiating Section 232 national security investigation into medical consumables and devices.
  20. VEMERIX, Products, reviewed September 5, 2026. Company-reported portfolio; no independent finding of equivalence or manufacturing scope.
  21. VEMERIX, Medical Device Contract Manufacturing (2026), August 2026 - Guide to contract manufacturing selection, regulatory file compilation, and cleanroom quality systems for private-label medical consumables.

Talk to VEMERIX

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care.